Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

NCT00588731 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Cannabidiol
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]